Small molecule · developed by Xenon Pharmaceuticals
XPF-001 is an oral drug given as 100 mg capsules.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00954356 | Phase 2 | Dental Pain | Completed | XENE |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Dental Pain
Updated Nov 1, 2026. Something wrong or missing? Report it on the XENE page.
See XENE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
XENE catalysts and pipeline →